At our clinics, we offer patients the latest evidence-based tests and treatments, and give them the opportunity to participate in clinical trials to advance our life-saving research. In 2019, we:
- performed 4,664 ultrasound scans in our clinics. This equates to approximately 388 women scanned per month, or 90 scans per week.
- recruited a total of 1,138 participants to clinical trials at our centre
- improved our patient experience score from 62% in 2016 to an average of 88% in 2019
In 2019, we treated 35 women with a rare condition called Chronic Histiocytic Intervillositis (CHI) at our clinic. These women received a treatment plan using antenatal immunosuppressive therapies. To date, all pregnancies that continued beyond 20 weeks’ gestation ended in a live birth. This is particularly remarkable given that CHI is a condition with a 50% mortality rate.
Outcomes are improved for women who are cared for at our clinics: since 2010, the stillbirth rate at St Mary’s Hospital has fallen from 6.9 per 1,000 live births to 4.7 per 1,000 in 2018.
10 years of the Manchester Placenta Clinic
In 2019, we celebrated 10 years since we opened the Manchester Placenta Clinic. The clinic was set up to deepen our understanding of the devastating pregnancy complications that can result in placental dysfunction. The clinic focuses on women with fetal growth restriction, and provides these women with extra scans using the latest technologies to monitor their pregnancies.
The clinic has also collected a large amount of information and created a substantial and robust dataset that enables us to improve patient care. In 2019 alone, our clinic scanned over 2,600 women and collected data and biological samples from over 1,000 women.